Inferior Vena Cava (IVC) Filter Market is estimated to be US$ 1887.4 Million by 2034 with a CAGR of 10.10% during the forecast period

The inferior vena cava is a large vein that basically carries the deoxygenated blood from the lower and mid-level body into the right atrium of the heart. It is formed by the joining of the right and left common iliac veins, it is usually at the level of the fifth lumbar vertebra. The IVC filter are the cone like devices that is inserted in the inferior vena cava which is just below the kidney.

IVC filters are used as a treatment to prevent pulmonary embolism. The global Inferior Vena Cava (IVC) Filter Market is expected to grow in a healthy rate. The IVC filters have also gained the grasp over the years due to factors such as the rising prevalence of cardiac ailments and the growing demand for minimally invasive technique in surgical treatment. Technological advancement is expected to push the Inferior Vena Cava (IVC) Filter Market growth in future.Inferior Vena Cava (IVC) Filter Market was valued at US$ 865.8 Million in 2024 and is projected to grow at a CAGR of 10.10% to reach US$ 1887.4 Million by 2034.

The report “Global Inferior Vena Cava (IVC) Filter Market, By Product (Permanent IVC Filter and Retrievable IVC Filter), By Application (Treatment Venous Thromboembolism (VTE), and Prevent Pulmonary Embolism (PE)), By End User (Ambulatory Surgical Centre’s (ASCs) and Hospitals), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034”

 Key Highlights:

• In June 2020, Argon Medical launched new two IVC Filter Retrieval Kits. The new launched kits were Single-Loop and Triple-Loop, which were designed with a coil-reinforced outer sheath with the strength needed to detach the filter legs and it also consists of a radiopaque band on the distal end of the inner sheath as well as outer sheath. 
• In June 2022, Cordis-X invested USD 11.5 million in Adient Medical, it is a manufacturer for the next generation absorbable inferior vena cava (IVC) filter that provides protection against pulmonary embolisms (PE). Cordis-X invests in Adient Medical a developer of fully Absorbable IVC Filter. Adient has obtained investigational device exemption approval for both a 510(k) study for therapeutic indication and a premarket approval application for a prophylactic indication. This Investment will help Cordis-X to strengthen its position in the market with expansion of its IVC business.
• In December 2022, Zylox-Tonbridge Medical Technology was granted marketing approval by the National Medical Products Administration of the people’s Republic of China, for their Retrievable Inferior Vena cava Filter-ZYLOX octoplus TM. The ZYLOX OctoplusTM IVC Filter medical is a cutting-edge next-generation medical device designed in-house for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Analyst View:

The key factor in driving the growth of the Inferior Vena Cava Market is the rising of certain diseases such as Venous Thromboembolism, Pulmonary Embolism. As aging population is growing there is an increase in the incidence of venous thromboembolism which leads and increase in the prophylaxis in patients and due to which there is a lack of alternative therapy in turn, facilitate the target market growth. As a result, market competition will be more aggravate and challenging, and big international corporations and start-ups will struggle to establish the position in Inferior Vena Cava (IVC) Filter Market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Inferior Vena Cava (IVC) Filter Market, By Product (Permanent IVC Filter and Retrievable IVC Filter), By Application (Treatment Venous Thromboembolism (VTE), and Prevent Pulmonary Embolism (PE)), By End User (Ambulatory Surgical Centre’s (ASCs) and Hospitals), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”

Key Market Insights from the report

Inferior Vena Cava (IVC) Filter Market was valued at US$ 865.8 Million in 2024 and is projected to grow at a CAGR of 10.10% to reach US$ 1887.4 Million by 2034.The Inferior Vena Cava (IVC) Filter Market is segmented based on by Product, by Application and by Region.

• Based on Product type, Inferior Vena Cava (IVC) Filter Market is segmented into Permanent IVC Filter and Retrievable IVC Filter.
• Based on Application, Inferior Vena Cava (IVC) Filter Market is segmented into Treatment of Venous Thromboembolism (VTE) and prevent Pulmonary Embolism (PE).
• By Region, the Inferior Vena Cava (IVC) Filter Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Inferior vena cava Market:

The prominent players operating in the Inferior Vena Cava (IVC) Filter Market includes, Becton Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Cook Medical, B. Braun Melsungen AG, Excellent Inc , Fakuda Denshi co. Ltd. , Biosensors International Group, Baxter International Inc. , Abbott Laboratories, Volcano Corporation. 

To know more

Contact Us:

Sales

Prophecy Market Insights

 U.S.  1 860 531 2574

RoW: 917775049802

Email- [email protected]

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com